Mechanisms for increased healthcare expenditures among patients with device detected atrial fibrillation

نویسندگان

چکیده

Abstract Funding Acknowledgements Type of funding sources: None. Background There are limited data on the mechanisms increased healthcare costs among patients with atrial fibrillation (AF). Differences in expenditures at various sites service may provide mechanistic insight into cost differentials between and without AF. Objective To assess for associations device detected AF (ddAF). Methods Using de-identified Optum® Clinformatics® U.S. claims database (2015 to 2020) linked Medtronic CareLink® database, we identified CIED that transmitted ≥6 months post-implant (baseline period). Annualized per-patient during follow-up, subdivided by site service, were compared ddAF adjusted 2020 US Dollars. Analyses geographical region, insurance type, CHA2DS2-VASc Score, implant year. The ten most common hospitalization diagnosis-related groups (DRG) analyzed ddAF. Results Of 21,391 (72.9±10.9 yrs; 56.3% male) analyzed, 7,798 (36.5%) had Compared ddAF, those higher annualized total (adjusted ratio (CR) 1.21 (1.16-1.25); p<0.001). no differences clinic health CR 1.01 (0.98-1.04); p=0.63). Patients inpatient 1.29 (1.21-1.37); p<0.001), outpatient 1.20 (1.15-1.24); long-term care facility 1.39 (1.24-1.55); pharmacy 1.14 (1.10-1.19); p<0.001) than (fig). Heart failure hospitalizations accounted highest percentage DRGs. similar percentages DRGs heart (ddAF: 41.9%; ddAF: 41.3%). 9.7% arrhythmia-related cohort. Conclusion Increased hospitalization, long term facility, largely responsible differential It is likely account a significant portion associated Further research specific interventions occur which produce needed.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Diastolic Electrocardiographic Parameters Predict Implantable Device Detected Asymptomatic Atrial Fibrillation

BACKGROUND Atrial fibrillation is the most common clinically significant arrhythmia. It is now established that atrial high-rate episodes are highly correlated with atrial fibrillation. AIMS To investigate the relation between diastolic electrocardiographic parameters and subclinical atrial fibrillation detected by cardiac implantable electronic devices. STUDY DESIGN Ccross-sectional study....

متن کامل

Anticoagulation Management in Patients with Pacemaker-Detected Atrial Fibrillation

INTRODUCTION In patients with an implanted pacemaker, asymptomatic atrial fibrillation (AF) is associated with an increased risk of thrombo-embolic complications. There is still no consensus which duration of episodes of atrial fibrillation should be taken as an indicator for inclusion of oral anticoagulation therapy (OAC). MATERIAL AND METHODS A total of 104 patients who had no AF episodes i...

متن کامل

Increased IL-17A in Atrial Fibrillation Correlates with Neutrophil to Lymphocyte Ratio

Background: Atrial Fibrillation (AF) is the most common cardiac arrhythmia and an independent risk factor for stroke among the elderly. A role for inflammation in the atrial remodeling as well as development and recurrence of AF is known. Objective: To compare IL-17A between patients with different types of AF and healthy individuals. Methods: IL-17A was measured in sera of 112 patients and 107...

متن کامل

Warfarin treatment among Finnish patients with atrial fibrillation: retrospective registry study based on primary healthcare data

OBJECTIVE To assess the frequency of warfarin use, the achieved international normalised ratio (INR) balance among warfarin users and the primary healthcare outpatient costs of patients with atrial fibrillation (AF). DESIGN Retrospective, non-interventional registry study. SETTING Primary healthcare. PARTICIPANTS All patients with AF (n=2746) treated in one Finnish health centre between O...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Europace

سال: 2023

ISSN: ['1099-5129', '1532-2092']

DOI: https://doi.org/10.1093/europace/euad122.020